Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001418460) titled 'A first-in-human trial to assess safety of adenosine-lidocaine-magnesium (ALM) therapy for elective knee surgery' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety
Primary Sponsor: James Cook University
Condition:
anterior cruciate ligament reconstruction
Total knee arthroplasty
Osteoarthritis
anterior cruciate ligament reconstruction
Total knee arthroplasty
Osteoarthritis
Surgery - Other surgery
Musculoskeletal - Osteoarthritis
Musculoskeletal - Other muscular and ...